Exosome extracellular vesicles and methods of use
US-12109310-B2 · Oct 8, 2024 · US
Peptide for reducing the phosphate requirement and excretion from farm animals
US9708369B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9708369-B2 |
| Application number | US-201514735648-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 10, 2015 |
| Priority date | Oct 26, 2011 |
| Publication date | Jul 18, 2017 |
| Grant date | Jul 18, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are methods of altering metabolism of phosphate in a livestock via an antibody. The methods involve the development of an antibody against FGF-23 for the purpose of reducing phosphate excretion by an animal.
First claim
Opening claim text (preview).
What is claimed is: 1. A polypeptide consisting of an amino acid sequence comprising a NP-1 epitope selected from the group consisting of SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27, wherein the polypeptide is conjugated to a carrier protein. 2. A composition comprising a polypeptide and a carrier protein, wherein the polypeptide consists of an amino acid sequence comprising a NP-1 epitope selected from the group consisting of SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27, wherein the polypeptide is conjugated to the carrier protein and wherein the carrier protein is selected from the group consisting of bovine gamma globulin, FGF-23, bovine serum albumin, keyhole limpet hemocyanin, and ovalbumin. 3. The composition of claim 2 , further comprising an adjuvant selected from the group consisting of Freund's complete adjuvant and Freund's incomplete adjuvant. 4. The composition of claim 3 , wherein the composition comprises from about 50 micrograms to about 6 milligrams of the polypeptide conjugate.
Assignees
Inventors
Classifications
Immunostimulants · CPC title
the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines · CPC title
against growth factors {; against growth regulators} · CPC title
Fibroblast growth factor [FGF] · CPC title
Albumin; Keyhole limpet haemocyanin [KLH] · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9708369B2 cover?
- Disclosed are methods of altering metabolism of phosphate in a livestock via an antibody. The methods involve the development of an antibody against FGF-23 for the purpose of reducing phosphate excretion by an animal.
- Who is the assignee on this patent?
- Wisconsin Alumni Res Found
- What technology area does this patent fall under?
- Primary CPC classification A61K39/0005. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).